Syner-G BioPharma Group
Davida Blackman has extensive experience in the biotech and pharmaceutical industry. Davida currently holds the position of Vice President in CMC Development and Project Management for Biologics at Syner-G BioPharma Group since September 2021. Prior to that, they served as Senior Director at ProMetic Biotherapeutics from July 2007 to June 2021. Davida also worked at Human Genome Sciences as a Scientist from April 2003 to April 2004, and at EntreMed as a Research Scientist from 1997 to 2003.
Davida Blackman completed their Bachelor of Science degree in Chemistry at Mount St. Mary's University from 1986 to 1990. Davida then went on to pursue a Ph.D. in Biochemistry at the University of Notre Dame from 1991 to 1997.
This person is not in the org chart
This person is not in any offices
Syner-G BioPharma Group
Syner-G BioPharma Group provides in-depth expertise across the three key elements of Chemistry, Manufacturing, and Controls (CMC): Regulatory Services, Technical Development, and Quality/IT. We call this CMC 360™. We also provide medical writing services, with expertise in authoring a variety of regulatory documents across a wide range of therapeutic areas and in all phases of development. Our regulatory affairs services include the development and implementation of global regulatory strategic plans, regulatory agency meeting support, and electronic submissions to regulatory authorities around the world. We have the skill set and experience to guide your prime asset through any development challenges and along the ever-changing maze of regulatory filing pathways, to a position of full compliance, and high quality. Our expertise spans small molecules, peptides, oligonucleotides, biologics, monoclonal antibodies, antibody-drug conjugates, and cell and gene therapy products.